India Gets Its First Alzheimer’s Disease-Modifying Therapy: What The Launch Of Lormalzi Means

India Gets Its First Alzheimer’s Disease-Modifying Therapy: What The Launch Of Lormalzi Means

India has entered a new chapter in neurological healthcare with the launch of Lormalzi, the country’s first approved amyloid-targeting therapy for Alzheimer’s disease. Developed by Eli Lilly, the drug — scientifically known as donanemab — offers new hope for patients in the early stages of Alzheimer’s by aiming to slow the progression of the disease rather than merely manage symptoms. Alzheimer’s disease is the most common form of dementia, a pr…